<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of inserm-00955157</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-20T16:20:22+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.</title>
            <author role="aut">
              <persName>
                <forename type="first">Laura</forename>
                <surname>Richert</surname>
              </persName>
              <email type="md5">0d766b36444a06a0af72e53d1044fdfa</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="string">laura-richert</idno>
              <idno type="idhal" notation="numeric">766869</idno>
              <idno type="halauthorid" notation="string">196875-766869</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7682-2225</idno>
              <affiliation ref="#struct-220073"/>
              <affiliation ref="#struct-300122"/>
              <affiliation ref="#struct-55677"/>
              <affiliation ref="#struct-1065981"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Adélaïde</forename>
                <surname>Doussau</surname>
              </persName>
              <email type="md5">1ffa5b8822a01cb5dedbf184627f8fcb</email>
              <email type="domain">isped.u-bordeaux2.fr</email>
              <idno type="idhal" notation="numeric">894624</idno>
              <idno type="halauthorid" notation="string">541699-894624</idno>
              <affiliation ref="#struct-55677"/>
              <affiliation ref="#struct-300122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jean-Daniel</forename>
                <surname>Lelièvre</surname>
              </persName>
              <email type="md5">56498148cef8f3ef39804eb08fde508a</email>
              <email type="domain">hmn.aphp.fr</email>
              <idno type="idhal" notation="numeric">759950</idno>
              <idno type="halauthorid" notation="string">321455-759950</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8182-3628</idno>
              <idno type="IDREF">https://www.idref.fr/074657313</idno>
              <affiliation ref="#struct-266797"/>
              <affiliation ref="#struct-220073"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Vincent</forename>
                <surname>Arnold</surname>
              </persName>
              <email type="md5">4e0f8a8d4e1450f6dbce0a0724eb0e87</email>
              <email type="domain">gmail.com</email>
              <idno type="idhal" notation="numeric">953527</idno>
              <idno type="halauthorid" notation="string">778107-953527</idno>
              <affiliation ref="#struct-55677"/>
              <affiliation ref="#struct-220073"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Véronique</forename>
                <surname>Rieux</surname>
              </persName>
              <email type="md5">f8d26f9bfa11ec5ff051fe205b9583d4</email>
              <email type="domain">anrs.fr</email>
              <idno type="idhal" notation="numeric">953528</idno>
              <idno type="halauthorid" notation="string">807541-953528</idno>
              <affiliation ref="#struct-300028"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Amel</forename>
                <surname>Bouakane</surname>
              </persName>
              <email type="md5">2d6c317b6743358794fb0c5bfc2cb211</email>
              <email type="domain">anrs.fr</email>
              <idno type="idhal" notation="numeric">953529</idno>
              <idno type="halauthorid" notation="string">807542-953529</idno>
              <idno type="IDREF">https://www.idref.fr/144413132</idno>
              <idno type="VIAF">https://viaf.org/viaf/200151873</idno>
              <affiliation ref="#struct-300028"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Yves</forename>
                <surname>Lévy</surname>
              </persName>
              <email type="md5">9858d2cc869e5bf886749f3e55bffd8a</email>
              <email type="domain">hmn.aphp.fr</email>
              <idno type="idhal" notation="numeric">759951</idno>
              <idno type="halauthorid" notation="string">321458-759951</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-5549-6256</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-4224-3137</idno>
              <idno type="IDREF">https://www.idref.fr/032554796</idno>
              <affiliation ref="#struct-220073"/>
              <affiliation ref="#struct-103061"/>
              <affiliation ref="#struct-266797"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Geneviève</forename>
                <surname>Chêne</surname>
              </persName>
              <email type="md5">0e79cbeaa65e57d0de03d25fdbb0b191</email>
              <email type="domain">isped.u-bordeaux2.fr</email>
              <idno type="idhal" notation="numeric">842202</idno>
              <idno type="halauthorid" notation="string">131533-842202</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8368-6460</idno>
              <affiliation ref="#struct-55677"/>
              <affiliation ref="#struct-220073"/>
              <affiliation ref="#struct-300122"/>
            </author>
            <author role="crp">
              <persName>
                <forename type="first">Rodolphe</forename>
                <surname>Thiébaut</surname>
              </persName>
              <email type="md5">242f217052cdd1b15e9288ab507c175b</email>
              <email type="domain">u-bordeaux.fr</email>
              <idno type="idhal" notation="string">rodolphe-thiebaut</idno>
              <idno type="idhal" notation="numeric">175125</idno>
              <idno type="halauthorid" notation="string">32082-175125</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-5235-3962</idno>
              <idno type="IDREF">https://www.idref.fr/071580735</idno>
              <affiliation ref="#struct-55677"/>
              <affiliation ref="#struct-300122"/>
              <affiliation ref="#struct-220073"/>
              <affiliation ref="#struct-1065981"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Ed.</forename>
                <surname>BMC</surname>
              </persName>
              <email type="md5">7bc004cf734e1645c1468c005ceafbd9</email>
              <email type="domain">biomedcentral.com.invalid</email>
            </editor>
            <funder ref="#projanr-37855"/>
            <funder>The Vaccine Research Institute (VRI) is funded by the French government and receives support from the French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS). L. Richert received a PhD grant financed by Sidaction (http://www.sidaction. org). A. Doussau received a PhD grant financed by the French National Cancer Institute (INCa, http://www.e-cancer.fr).</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2014-03-04 05:09:04</date>
              <date type="whenModified">2026-04-03 03:02:51</date>
              <date type="whenReleased">2014-03-04 11:30:56</date>
              <date type="whenProduced">2014-02-26</date>
              <date type="whenEndEmbargoed">2014-03-04</date>
              <ref type="file" target="https://inserm.hal.science/inserm-00955157v1/document">
                <date notBefore="2014-03-04"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://inserm.hal.science/inserm-00955157v1/file/1745-6215-15-68.pdf" id="file-955157-535132">
                <date notBefore="2014-03-04"/>
              </ref>
              <ref type="annex" subtype="other" n="0" target="https://inserm.hal.science/inserm-00955157v1/file/1745-6215-15-68.xml" id="file-955157-535131">
                <date notBefore="2014-03-04"/>
              </ref>
              <ref type="externalLink" target="https://trialsjournal.biomedcentral.com/track/pdf/10.1186/1745-6215-15-68"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="151596">
                <persName>
                  <forename>Ed.</forename>
                  <surname>BMC</surname>
                </persName>
                <email type="md5">7bc004cf734e1645c1468c005ceafbd9</email>
                <email type="domain">biomedcentral.com.invalid</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">inserm-00955157</idno>
            <idno type="halUri">https://inserm.hal.science/inserm-00955157</idno>
            <idno type="halBibtex">richert:inserm-00955157</idno>
            <idno type="halRefHtml">&lt;i&gt;Trials&lt;/i&gt;, 2014, 15 (1), pp.68. &lt;a target="_blank" href="https://dx.doi.org/10.1186/1745-6215-15-68"&gt;&amp;#x27E8;10.1186/1745-6215-15-68&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Trials, 2014, 15 (1), pp.68. &amp;#x27E8;10.1186/1745-6215-15-68&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-955157-535132"/><ref corresp="#file-955157-535131"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="INRIA">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="ANRS">Agence Nationale de Recherches sur le Sida</idno>
            <idno type="stamp" n="INRIA-BORDEAUX">INRIA Bordeaux - Sud-Ouest</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="INRIA_TEST">INRIA - Institut National de Recherche en Informatique et en Automatique</idno>
            <idno type="stamp" n="IMRB" corresp="INSERM">Institut Mondor de Recherche Biomédicale</idno>
            <idno type="stamp" n="UPEC" corresp="CV_UPEC">Université Paris-Est Créteil Val-de-Marne</idno>
            <idno type="stamp" n="TESTALAIN1">TESTALAIN1</idno>
            <idno type="stamp" n="TESTBORDEAUX">TESTBORDEAUX</idno>
            <idno type="stamp" n="INRIA2">INRIA 2</idno>
            <idno type="stamp" n="ANR">ANR</idno>
            <idno type="stamp" n="TEST-UPEC-ODD" corresp="UPEC">TEST UPEC ODD</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Laura</forename>
                    <surname>Richert</surname>
                  </persName>
                  <email type="md5">0d766b36444a06a0af72e53d1044fdfa</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="string">laura-richert</idno>
                  <idno type="idhal" notation="numeric">766869</idno>
                  <idno type="halauthorid" notation="string">196875-766869</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7682-2225</idno>
                  <affiliation ref="#struct-220073"/>
                  <affiliation ref="#struct-300122"/>
                  <affiliation ref="#struct-55677"/>
                  <affiliation ref="#struct-1065981"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Adélaïde</forename>
                    <surname>Doussau</surname>
                  </persName>
                  <email type="md5">1ffa5b8822a01cb5dedbf184627f8fcb</email>
                  <email type="domain">isped.u-bordeaux2.fr</email>
                  <idno type="idhal" notation="numeric">894624</idno>
                  <idno type="halauthorid" notation="string">541699-894624</idno>
                  <affiliation ref="#struct-55677"/>
                  <affiliation ref="#struct-300122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jean-Daniel</forename>
                    <surname>Lelièvre</surname>
                  </persName>
                  <email type="md5">56498148cef8f3ef39804eb08fde508a</email>
                  <email type="domain">hmn.aphp.fr</email>
                  <idno type="idhal" notation="numeric">759950</idno>
                  <idno type="halauthorid" notation="string">321455-759950</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8182-3628</idno>
                  <idno type="IDREF">https://www.idref.fr/074657313</idno>
                  <affiliation ref="#struct-266797"/>
                  <affiliation ref="#struct-220073"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Vincent</forename>
                    <surname>Arnold</surname>
                  </persName>
                  <email type="md5">4e0f8a8d4e1450f6dbce0a0724eb0e87</email>
                  <email type="domain">gmail.com</email>
                  <idno type="idhal" notation="numeric">953527</idno>
                  <idno type="halauthorid" notation="string">778107-953527</idno>
                  <affiliation ref="#struct-55677"/>
                  <affiliation ref="#struct-220073"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Véronique</forename>
                    <surname>Rieux</surname>
                  </persName>
                  <email type="md5">f8d26f9bfa11ec5ff051fe205b9583d4</email>
                  <email type="domain">anrs.fr</email>
                  <idno type="idhal" notation="numeric">953528</idno>
                  <idno type="halauthorid" notation="string">807541-953528</idno>
                  <affiliation ref="#struct-300028"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Amel</forename>
                    <surname>Bouakane</surname>
                  </persName>
                  <email type="md5">2d6c317b6743358794fb0c5bfc2cb211</email>
                  <email type="domain">anrs.fr</email>
                  <idno type="idhal" notation="numeric">953529</idno>
                  <idno type="halauthorid" notation="string">807542-953529</idno>
                  <idno type="IDREF">https://www.idref.fr/144413132</idno>
                  <idno type="VIAF">https://viaf.org/viaf/200151873</idno>
                  <affiliation ref="#struct-300028"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Yves</forename>
                    <surname>Lévy</surname>
                  </persName>
                  <email type="md5">9858d2cc869e5bf886749f3e55bffd8a</email>
                  <email type="domain">hmn.aphp.fr</email>
                  <idno type="idhal" notation="numeric">759951</idno>
                  <idno type="halauthorid" notation="string">321458-759951</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-5549-6256</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-4224-3137</idno>
                  <idno type="IDREF">https://www.idref.fr/032554796</idno>
                  <affiliation ref="#struct-220073"/>
                  <affiliation ref="#struct-103061"/>
                  <affiliation ref="#struct-266797"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Geneviève</forename>
                    <surname>Chêne</surname>
                  </persName>
                  <email type="md5">0e79cbeaa65e57d0de03d25fdbb0b191</email>
                  <email type="domain">isped.u-bordeaux2.fr</email>
                  <idno type="idhal" notation="numeric">842202</idno>
                  <idno type="halauthorid" notation="string">131533-842202</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8368-6460</idno>
                  <affiliation ref="#struct-55677"/>
                  <affiliation ref="#struct-220073"/>
                  <affiliation ref="#struct-300122"/>
                </author>
                <author role="crp">
                  <persName>
                    <forename type="first">Rodolphe</forename>
                    <surname>Thiébaut</surname>
                  </persName>
                  <email type="md5">242f217052cdd1b15e9288ab507c175b</email>
                  <email type="domain">u-bordeaux.fr</email>
                  <idno type="idhal" notation="string">rodolphe-thiebaut</idno>
                  <idno type="idhal" notation="numeric">175125</idno>
                  <idno type="halauthorid" notation="string">32082-175125</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-5235-3962</idno>
                  <idno type="IDREF">https://www.idref.fr/071580735</idno>
                  <affiliation ref="#struct-55677"/>
                  <affiliation ref="#struct-300122"/>
                  <affiliation ref="#struct-220073"/>
                  <affiliation ref="#struct-1065981"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">2453</idno>
                <idno type="issn">1745-6215</idno>
                <title level="j">Trials</title>
                <imprint>
                  <publisher>BioMed Central</publisher>
                  <biblScope unit="volume">15</biblScope>
                  <biblScope unit="issue">1</biblScope>
                  <biblScope unit="pp">68</biblScope>
                  <date type="datePub">2014-02-26</date>
                  <date type="dateEpub">2014-02-26</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1186/1745-6215-15-68</idno>
              <idno type="pubmed">24571662</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">HIV vaccine</term>
                <term xml:lang="en">Safety</term>
                <term xml:lang="en">Stopping rule</term>
                <term xml:lang="en">Bayes</term>
                <term xml:lang="en">Frequentist</term>
                <term xml:lang="en">Randomisation</term>
                <term xml:lang="en">Phase II</term>
                <term xml:lang="en">Phase I</term>
                <term xml:lang="en">Design</term>
                <term xml:lang="en">Clinical trial</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BACKGROUND: Many candidate vaccine strategies against human immunodeficiency virus (HIV) infection are under study, but their clinical development is lengthy and iterative. To accelerate HIV vaccine development optimised trial designs are needed. We propose a randomised multi-arm phase I/II design for early stage development of several vaccine strategies, aiming at rapidly discarding those that are unsafe or non-immunogenic. METHODS: We explored early stage designs to evaluate both the safety and the immunogenicity of four heterologous prime-boost HIV vaccine strategies in parallel. One of the vaccines used as a prime and boost in the different strategies (vaccine 1) has yet to be tested in humans, thus requiring a phase I safety evaluation. However, its toxicity risk is considered minimal based on data from similar vaccines. We newly adapted a randomised phase II trial by integrating an early safety decision rule, emulating that of a phase I study. We evaluated the operating characteristics of the proposed design in simulation studies with either a fixed-sample frequentist or a continuous Bayesian safety decision rule and projected timelines for the trial. RESULTS: We propose a randomised four-arm phase I/II design with two independent binary endpoints for safety and immunogenicity. Immunogenicity evaluation at trial end is based on a single-stage Fleming design per arm, comparing the observed proportion of responders in an immunogenicity screening assay to an unacceptably low proportion, without direct comparisons between arms. Randomisation limits heterogeneity in volunteer characteristics between arms. To avoid exposure of additional participants to an unsafe vaccine during the vaccine boost phase, an early safety decision rule is imposed on the arm starting with vaccine 1 injections. In simulations of the design with either decision rule, the risks of erroneous conclusions were controlled &lt;15%. Flexibility in trial conduct is greater with the continuous Bayesian rule. A 12-month gain in timelines is expected by this optimised design. Other existing designs such as bivariate or seamless phase I/II designs did not offer a clear-cut alternative. CONCLUSIONS: By combining phase I and phase II evaluations in a multi-arm trial, the proposed optimised design allows for accelerating early stage clinical development of HIV vaccine strategies.</p>
            </abstract>
            <particDesc>
              <org type="consortium">Vaccine Research Institute (VRI)</org>
            </particDesc>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-220073" status="VALID">
          <orgName>Vaccine Research Institute [Créteil, France]</orgName>
          <orgName type="acronym">VRI</orgName>
          <desc>
            <address>
              <addrLine>61 avenue du Général de Gaulle 94010 Créteil Cedex France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.recherche-vaccinvih.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-420786" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300122" status="VALID">
          <idno type="IdRef">028228421</idno>
          <idno type="ROR">https://ror.org/01hq89f96</idno>
          <orgName>Centre Hospitalier Universitaire de Bordeaux</orgName>
          <orgName type="acronym">CHU Bordeaux</orgName>
          <desc>
            <address>
              <addrLine>12 rue Dubernat 33400 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-55677" status="OLD">
          <orgName>Epidémiologie et Biostatistique [Bordeaux]</orgName>
          <desc>
            <address>
              <addrLine>146, rue Léo-Saignat 33076 Bordeaux</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-91134" type="direct"/>
            <relation name="U897" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="researchteam" xml:id="struct-1065981" status="OLD">
          <idno type="RNSR">201321095C</idno>
          <orgName>Statistics In System biology and Translational Medicine</orgName>
          <orgName type="acronym">SISTM</orgName>
          <date type="start">2013-04-02</date>
          <date type="end">2015-12-31</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-55677" type="direct"/>
            <relation active="#struct-91134" type="indirect"/>
            <relation name="U897" active="#struct-303623" type="indirect"/>
            <relation active="#struct-104751" type="direct"/>
            <relation active="#struct-300009" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-266797" status="VALID">
          <idno type="IdRef">151294895</idno>
          <idno type="RNSR">200919261B</idno>
          <idno type="ROR">https://ror.org/04qe59j94</idno>
          <idno type="Wikidata">Q30261452</idno>
          <orgName>Institut Mondor de Recherche Biomédicale</orgName>
          <orgName type="acronym">IMRB</orgName>
          <desc>
            <address>
              <addrLine>8 rue du Général Sarrail 94010 Créteil</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.imrb.inserm.fr/</ref>
          </desc>
          <listRelation>
            <relation name="U955" active="#struct-303623" type="direct"/>
            <relation name="UMR955" active="#struct-420786" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300028" status="VALID">
          <orgName>ANRS France Recherche Nord &amp; sud Sida-hiv hépatites</orgName>
          <desc>
            <address>
              <addrLine>France Recherche Nord &amp; sud Sida-hiv hépatites</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.anrs.fr/fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-103061" status="VALID">
          <orgName>Groupe Henri Mondor-Albert Chenevier</orgName>
          <desc>
            <address>
              <addrLine>Créteil</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-420786" status="VALID">
          <idno type="IdRef">028021037</idno>
          <idno type="ISNI">0000000121497878</idno>
          <idno type="ROR">https://ror.org/05ggc9x40</idno>
          <orgName>Université Paris-Est Créteil Val-de-Marne - Paris 12</orgName>
          <orgName type="acronym">UPEC UP12</orgName>
          <date type="start">1970-01-01</date>
          <desc>
            <address>
              <addrLine>61 avenue du Général de Gaulle - 94010 Créteil cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-pec.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-91134" status="OLD">
          <orgName>Université Bordeaux Segalen - Bordeaux 2</orgName>
          <desc>
            <address>
              <addrLine>146 rue Léo Saignat - 33076 Bordeaux cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-bordeauxsegalen.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-104751" status="VALID">
          <idno type="RNSR">200818243Z</idno>
          <idno type="ROR">https://ror.org/03tjcj052</idno>
          <orgName>Centre Inria de l'Université de Bordeaux</orgName>
          <desc>
            <address>
              <addrLine>200, avenue de la Vieille Tour, 33405 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/bordeaux/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300009" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300009" status="VALID">
          <idno type="ROR">https://ror.org/02kvxyf05</idno>
          <orgName>Institut National de Recherche en Informatique et en Automatique</orgName>
          <orgName type="acronym">Inria</orgName>
          <desc>
            <address>
              <addrLine>Domaine de VoluceauRocquencourt - BP 10578153 Le Chesnay Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inria.fr/en/</ref>
          </desc>
        </org>
      </listOrg>
      <listOrg type="projects">
        <org type="anrProject" xml:id="projanr-37855" status="VALID">
          <idno type="anr">ANR-10-LABX-0077</idno>
          <idno type="program">Laboratoires d'excellence</idno>
          <orgName>VRI</orgName>
          <desc>Initiative for the creation of a Vaccine Research Institute</desc>
          <date type="start">2010</date>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>